Skip to Main Content

Paper Details

Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson's disease.
Neurobiol Aging
16
2021
DNM3, G2019S, LRRK2, LRRK2 gene, LRRK2 p, LRRK2 p.G2019S, LRRK2 p.G2019S heterozygotes, LRRK2 p.G2019S mutation, LRRK2 rs10878226, PD, Parkinson's disease, VAMP4, p.G2019S, patients, rs10878226, rs11578699
Author NameAffiliation
Mike A NallsNational Institute on Aging, National Institutes of Health
Mike A NallsNational Institute on Aging, National Institutes of Health
Andrew B SingletonNational Institute on Aging, National Institutes of Health
Andrew B SingletonNational Institute on Aging, National Institutes of Health
Alexis BriceResearch Unit U7 at INSERM, Research Unit UMR 7225 at the French National Centre for Scientific Research (CNRS) Research Unit UMR_7 at Sorbonne Universite, Institutet du Cerveau et de la Moelle epiniere (ICM)
Nicholas W WoodInstitute of Neurology, University College London
Nicholas W WoodInstitute of Neurology, University College London
Huw R MorrisInstitute of Neurology, University College London
  • 1 - 8

Datasets